Viewing Study NCT02345161

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:51 AM
Ignite Modification Date: 2026-01-26 @ 2:54 AM
Study NCT ID: NCT02345161
Status: COMPLETED
Last Update Posted: 2018-07-13
First Post: 2015-01-19
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Disease, Chronic Obstructive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Triple Therapy View
None Formoterol View
None Respiratory View
None COPD View
None Budesonide View
None Vilanterol View
None Fluticasone Furoate View
None Umeclidinium View
None Lung Function View